Author Archives: ijo013

Public PhD Defense, Week 21

portrett_hall_schartum-hansen_xHall Schartum-Hansen will defend his PhD thesis on Tueday May 23rd 2017
Trial lecture: Tuesday May 23rd 2017 at 10:15 AM
Topic: ”New markers and impact of secular trends on cardiovascular risk prediction”
Place: Stort auditorium, HUS, Sentralblokken 3rd floor, Jonas Lies vei 65
Public defense: Tuesday May 23rd 2017 at 12:15 PM
 Stort auditorium, HUS, Sentralblokken 3rd floor, Jonas Lies vei 65
Title of dissertation: Determinants of long-term outcome in patients With cardiovascular disease. Choline oxidation and loop diuretics- cross – sectional and prospective relationships in large Norwegian cohorts of patients With suspected or verified coronary heart disease”
1st opponent: Professor Stefan Agewall, Universiy of Oslo
2nd opponent: Professor Henrik Schirmer, UiT – The Arctic University of Norway

Press release  (Link in Norwegian)

New names

Sushma Bartaula-BrevikWe present Sushma Bartaula, PhD from University of Bergen. Sushma started her work in May 2017 as a post doctor at K2 and works in Burseruds Research Group (G5).
She will work on characerizing the pathways in leukemia cells from pations With acute myelogen leukemia, and especially the interaction wand communication betwen diffrent signaling pathways, under the guidance of Professor Øystein Bruserud. If anyone wants to say hello, you can find her in the 3rd floor of the lab-building

 

Innovation seminar this coming week

helgeNext week, innovation is in focus. Together with the Department of Biomedicine, we have invited Ulf Landegren, Professor of Molecular Medicine at the Department of Immunology, Genetics and Pathology and SciLifeLab, in Uppsala to hold the CCBIO / BBB seminar on Thursday 11.5 at 1430 in Auditorium 4, BBB.

In addition, there will be a lecture on innovation at 8.30 at BBB, room 9A109 on the 9th floor aimed at research group leaders. There will also be an opportunity to meet Ulf for individuall conversation. If you like to have an individual meeting with Ulf we your need feedback, preferably within the next Tuesday through email to Eystein or Helge.

Ultrafiolett EysteinUlf Landegren is distinguished both through outstanding scientific efforts, but also because he has over 40 patents and applications that have been commercialized. He has started a total of six companies and two of them have been sold to Affymetrix and Agilent, respectively.

We hope to see you at a seminar with Ulf Landegren next week.

Good weekend wishes

Eystein og Helge

 

Election Spring 2017

To staff in group C – candidate for the university board from K1 / MOF

Elections of Group C members from Group C start Monday May 8th, and Jorunn Skei from K1 will nominate. She hopes to raise and represent this important and highly competent group of technical and administrative staff at MOF / UiB.

Here is Jorunn’s candidate presentation:http://www.uib.no/foransatte/107367/jorunn-skei

With this election, you have 9 candidates to vote – use the right to vote:: http://www.uib.no/foransatte/104336/valg-v%C3%A5ren-2017

New names

dsc_0324We present Camilla Krakstad, MSc, PhD from the University of Bergen. Camilla began in April 2017 as a Professor and Group Leader of the Research Group for Gynecological Cancer at K2 / KK. She will continue the group’s focus on genetic studies and biomarkers for improved treatment of patients with gynecological cancer. If you want to say hi, you can find her in 4th floor at KK. ”

Guest speaker / Invitation to a seminar on “Alginate in cell transplantation and tissue engineering

We have the pleasure of hosting Prof. Berit L. Strand from the Norwegian university of Science and Technology (NTNU) in Trondheim. She will present important structure-function relationships of alginates and results from the use of alginate in the fields of islet encapsulation and tissue engineering. Her talk will be entitled: “Alginate in cell transplantation and tissue engineering”.

Alginate, a polysaccharide from seaweed, is known as a biocompatible polymer that form gels at physiological conditions, which makes it a popular material for cell encapsulation and tissue engineering. Alginate based capsules is proposed for immune protection of cells upon transplantation, e.g. insulin producing tissue for the treatment of Type 1 diabetes.

Date:  Thursday 4th of May

Time:  11:30 – 12:00 + discussions

Place:  BUS1: Meeting-room 6132 Aarskogsalen

New names

18052967_1319147584846673_870994871_nWe present Amra Grudic-Feta, a new research adviser at the Department of Clinical Science. Amra has her background from Department of Biomedicine and will be the administrative support in various parts of the research administration. If you want to say hi, you can find her on the 8th floor of the laboratory building

How to succeed with research at the Department of Clinical Science?

Ræder_portrettFirst you have to define your specific scientific goals and a reasonable time frame. The goals and time frame are perhaps most clearly formulated for the graduate students: One need to publish at least three papers within one´s field of interest and write a Thesis within the doctoral time frame. It is perhaps less clear what the goals are, if you are postdoctoral fellow or a younger researcher who would like a successful career in science, but a friend in Boston used to say that within the postdoctoral time period one should try to achieve the following three goals: to carry out interesting and publishable experiments, to publish a good paper, and obtain an independent grant. He also believed that these three goals were part of a cycle where they reinforced each other’s chance mutually: You do not get grants without papers, and you do not get papers without experiments and you do are not able to carry out experiments without any form of funding.

Portrett disputas på Det medisinsk-odontologiske fakultet,

Amra Grudic-Feta

Somewhere in the cycle, however, you need to jump in, and here we hope that a new initiative from the Department can come to your assistance: The Department has defined its goals for better research in the Strategy Plan, and in June we will employ a research consultant, Amra Grudic-Feta, who will help us reach several of these goals. In particular, she will contribute towards four of the defined goals:

– in the structured approach for writing grant applications (F2),

– in follow-up of grant calls as well as publication of these in K2News (F2),

– as a resource that can help career counseling and career research education (RIK1), and

– as a contact point (catalyst) who may help scientists navigate to find the desired advanced equipment and expertise within the Department (RIK2).

We wish Amra welcome to the Department and hope she can help you to reach your goals.

Helge